MedPath

Effect of anti lophomonas parasite treatment on patients chronic cough well-being

Phase 2
Recruiting
Conditions
Condition 1: chronic cough. Condition 2: Lophomonas Blattarum.
Cough
Registration Number
IRCT20091111002695N10
Lead Sponsor
Islamic Azad University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

patients suffering from more than one months cough who could not be controlled by past medical treatments
patients with normal physical examination
patients with normal chest-x-ray

Exclusion Criteria

drug allergy
proven asthma
Tuberculosis(TB), gastroesophageal reflux(GERD) , ear wax, Chronic Obstructive Pulmonary disease(COPD), Carcinoma,hemoptesis
Angiotensin converting enzyme inhibitors(ACEI) users

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ophomonas Blattarum being in smear or Bronchoalveolarlavage. Timepoint: Before intervention and 14 days after intervention. Method of measurement: Trichrome staining.;Chronic cough grading. Timepoint: Before intervention and 14 days after intervention. Method of measurement: Global Initiative for Asthma (GINA) guideline.
Secondary Outcome Measures
NameTimeMethod
Dyspnea. Timepoint: Before intervention and 14days after intervention. Method of measurement: physical examination.;Sputum inflammatory cells. Timepoint: Before intervention and 14days after intervention. Method of measurement: sputum cytology.;Dyspnea garding. Timepoint: Before intervention and 14 days after intervention. Method of measurement: GINA(global strategy for asthma).;Body temperature. Timepoint: Before intervention and 14days after intervention. Method of measurement: Thermometer.
© Copyright 2025. All Rights Reserved by MedPath